13F Holdings
中文EN

AGL agilon health, inc.

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1831097 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.0%
TTM net income YoY71.7%
TTM EPS YoY73.5%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-2.6%
Net margin-1.5%
FCF margin-0.3%
EBITDA margin-2.1%

Returns

ROE-29.7%
ROA-5.5%
ROIC (approx.)-79.4%
Asset turnover3.80x

Leverage & solvency

Liabilities / assets82.1%
Debt / equity0.11x
Current ratio1.13x
Interest coverage-22.38x

Cash quality & payout

Operating cash flow / net income0.05x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$5.93B$6.06B$4.32B$2.39B$1.52B
SG&A expense$238.54M$268.91M$285.76M$207.79M$427.50M
Operating income-$463.24M-$292.13M-$232.13M-$105.38M-$372.24M
Interest expense$6.64M$6.18M$6.66M$4.48M$6.15M
Pretax income-$404.10M-$248.83M-$194.46M-$90.67M-$382.98M
Income tax$1.25M$1.45M$791,000$1.64M$886,000
Net income-$391.35M-$260.15M-$262.60M-$106.55M-$406.49M
EBITDA-$434.64M-$267.67M-$211.97M-$91.61M-$357.57M
EPS (diluted)—————
Weighted avg. shares (diluted)413.97M410.97M408.92M408.15M372.93M
Balance sheet
Cash & equivalents$173.71M$188.23M$114.33M$475.91M$1.05B
Short-term investments———$411.90M$0
Receivables$673.79M$1.02B$942.46M$492.36M$293.41M
Current assets$1.10B$1.46B$1.48B$1.45B$1.37B
PP&E, net$25.42M$28.17M$27.58M$19.94M$9.16M
Goodwill$0$24.13M$24.13M$2.51M$41.54M
Intangibles$65.72M$72.77M$63.77M$18.45M$55.40M
Total assets$1.27B$1.73B$1.74B$1.70B$1.59B
Current liabilities$1.08B$1.15B$977.16M$535.09M$356.96M
Short-term debt$19.24M$0$6.25M$5.00M$5.00M
Long-term debt$15.75M$34.90M$32.31M$38.48M$43.40M
Total debt$34.99M$34.90M$38.56M$43.48M$48.40M
Total liabilities$1.14B$1.26B$1.08B$656.86M$494.66M
Shareholders' equity$126.73M$470.95M$661.84M$1.04B$1.09B
Net debt-$138.72M-$153.33M-$75.77M-$432.43M-$1.00B
Shares outstanding16.59M412.19M406.39M412.38M400.10M
Cash flow statement
Operating cash flow-$105.76M-$57.78M-$156.20M-$130.81M-$148.16M
Capital expenditure$13.24M$13.25M$15.83M$15.43M$6.56M
Free cash flow-$119.00M-$71.03M-$172.03M-$146.23M-$154.72M
Investing cash flow$88.61M$139.89M-$44.02M-$444.39M-$90.51M
Financing cash flow-$2.99M-$2.58M-$193.13M$28.06M$1.15B
Depreciation & amortization$28.59M$24.46M$20.16M$13.77M$14.67M
Stock-based compensation$49.12M$50.66M$69.50M$28.38M$292.39M
Share buybacks——$200.00M——

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.